Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma von Bommareddy, Praveen K., Patel, Anand, Hossain, Saamia, Kaufman, Howard L.

Volltext

Integrating oncolytic viruses in combination cancer immunotherapy von Bommareddy, Praveen K., Shettigar, Megha, Kaufman, Howard L.

Volltext

Oncolytic viruses: a new class of immunotherapy drugs von Kaufman, Howard L., Kohlhapp, Frederick J., Zloza, Andrew

Volltext

Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy von Kohlhapp, Frederick J, Kaufman, Howard L

Volltext

Clinical landscape of oncolytic virus research in 2020 von Macedo, Nicholas, Miller, David M, Haq, Rizwan, Kaufman, Howard L

Volltext

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma von Gross, Neil D., Miller, David M., Khushalani, Nikhil I., Divi, Vasu, Ruiz, Emily S., Lipson, Evan J., Meier, Friedegund, Su, Yungpo B., Swiecicki, Paul L., Atlas, Jennifer, Geiger, Jessica L., Hauschild, Axel, Choe, Jennifer H., Hughes, Brett G.M., Schadendorf, Dirk, Patel, Vishal A., Homsi, Jade, Taube, Janis M., Lim, Annette M., Ferrarotto, Renata, Kaufman, Howard L., Seebach, Frank, Lowy, Israel, Yoo, Suk-Young, Mathias, Melissa, Fenech, Keilah, Han, Hyunsil, Fury, Matthew G., Rischin, Danny

Volltext

Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma von Usmani, Saad Z., Nahi, Hareth, Mateos, Maria-Victoria, van de Donk, Niels W.C.J., Chari, Ajai, Kaufman, Jonathan L., Moreau, Philippe, Oriol, Albert, Plesner, Torben, Benboubker, Lotfi, Hellemans, Peter, Masterson, Tara, Clemens, Pamela L., Luo, Man, Liu, Kevin, San-Miguel, Jesus

Volltext

Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma von Chari, Ajai, Suvannasankha, Attaya, Fay, Joseph W., Arnulf, Bertrand, Kaufman, Jonathan L., Ifthikharuddin, Jainulabdeen J., Weiss, Brendan M., Krishnan, Amrita, Lentzsch, Suzanne, Comenzo, Raymond, Wang, Jianping, Nottage, Kerri, Chiu, Christopher, Khokhar, Nushmia Z., Ahmadi, Tahamtan, Lonial, Sagar

Volltext

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management von Bateman, Lucinda, Bested, Alison C., Bonilla, Hector F., Chheda, Bela V., Chu, Lily, Curtin, Jennifer M., Dempsey, Tania T., Dimmock, Mary E., Dowell, Theresa G., Felsenstein, Donna, Kaufman, David L., Klimas, Nancy G., Komaroff, Anthony L., Lapp, Charles W., Levine, Susan M., Montoya, Jose G., Natelson, Benjamin H., Peterson, Daniel L., Podell, Richard N., Rey, Irma R., Ruhoy, Ilene S., Vera-Nunez, Maria A., Yellman, Brayden P.

Volltext

Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study von Bahlis, Nizar J., Dimopoulos, Meletios A., White, Darrell J., Benboubker, Lotfi, Cook, Gordon, Leiba, Merav, Ho, P. Joy, Kim, Kihyun, Takezako, Naoki, Moreau, Philippe, Kaufman, Jonathan L., Krevvata, Maria, Chiu, Christopher, Qin, Xiang, Okonkwo, Linda, Trivedi, Sonali, Ukropec, Jon, Qi, Ming, San-Miguel, Jesus

Volltext

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial von Kaufman, Howard L, Prof, Russell, Jeffery, MD, Hamid, Omid, MD, Bhatia, Shailender, MD, Terheyden, Patrick, MD, D'Angelo, Sandra P, MD, Shih, Kent C, MD, Lebbé, Céleste, Prof, Linette, Gerald P, MD, Milella, Michele, MD, Brownell, Isaac, MD, Lewis, Karl D, MD, Lorch, Jochen H, MD, Chin, Kevin, MD, Mahnke, Lisa, MD, von Heydebreck, Anja, PhD, Cuillerot, Jean-Marie, MD, Nghiem, Paul, Prof

Volltext

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer von Mehnert, Janice M, Panda, Anshuman, Zhong, Hua, Hirshfield, Kim, Damare, Sherri, Lane, Katherine, Sokol, Levi, Stein, Mark N, Rodriguez-Rodriquez, Lorna, Kaufman, Howard L, Ali, Siraj, Ross, Jeffrey S, Pavlick, Dean C, Bhanot, Gyan, White, Eileen P, DiPaola, Robert S, Lovell, Ann, Cheng, Jonathan, Ganesan, Shridar

Volltext

Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination von Fine, Amena Smith, Nemeth, Christina L, Kaufman, Miriam L, Fatemi, Ali

Volltext

Daratumumab in multiple myeloma von Nooka, Ajay K., Kaufman, Jonathan L., Hofmeister, Craig C., Joseph, Nisha S., Heffner, Thomas L., Gupta, Vikas A., Sullivan, Harold C., Neish, Andrew S., Dhodapkar, Madhav V., Lonial, Sagar

Volltext

Immunotherapy for Nonmelanoma Skin Cancer: Facts and Hopes von Shalhout, Sophia Z, Kaufman, Howard L, Emerick, Kevin S, Miller, David M

Volltext

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis von Barwick, Benjamin G., Neri, Paola, Bahlis, Nizar J., Nooka, Ajay K., Dhodapkar, Madhav V., Jaye, David L., Hofmeister, Craig C., Kaufman, Jonathan L., Gupta, Vikas A., Auclair, Daniel, Keats, Jonathan J., Lonial, Sagar, Vertino, Paula M., Boise, Lawrence H.

Volltext

Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma von Shah, Jatin J., Stadtmauer, Edward A., Abonour, Rafat, Cohen, Adam D., Bensinger, William I., Gasparetto, Cristina, Kaufman, Jonathan L., Lentzsch, Suzanne, Vogl, Dan T., Gomes, Christina L., Pascucci, Natalia, Smith, David D., Orlowski, Robert Z., Durie, BrianG.M.

Volltext

Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy von Rehman, Hasan, Silk, Ann W., Kane, Michael P., Kaufman, Howard L.

Volltext

Homotaurine limits the spreading of T cell autoreactivity within the CNS and ameliorates disease in a model of multiple sclerosis von Tian, Jide, Song, Min, Kaufman, Daniel L.

Volltext

Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III-IV melanoma von Andtbacka, Robert H I, Collichio, Frances, Harrington, Kevin J, Middleton, Mark R, Downey, Gerald, Ӧhrling, Katarina, Kaufman, Howard L

Volltext